•
Rapidly
increasing health care expenses
are no longer sustainable.
•
Cost calculation in radiotherapy is feasible, accurate resource cost data
however
remain scarce
.
•
Optimising
efficiency
is important, hypofractionation compensates for
the cost of higher complexity, while safeguarding the quality.
•
Cost-effectiveness analyses
are gaining attention in radiation therapy,
but challenges remain
•
to define the adequate timing of the analysis
•
to collect the required outcome measures of survival and quality of life
•
Cost calculations and economic evaluations gradually become a
prerequisite for financing
of innovative technologies and techniques.
take home messages